Lung resection in a neoadjuvant protocol.
Neoadjuvant therapy was defined as a cytoreductive therapy administered prior to a definitive locoregional treatment--surgical resection. While surgical resection can be curative in patients diagnosed with localized early-stage non-small cell lung cancer, patients with nodal (N1, N2) disease are generally not candidates for exclusive surgery. Inductive therapy can improve the microscopic metastatic disease, eradicate the primary tumor and thereby improve survival.
Klein
J
J
1st Clinic of Surgery, Palacke University Teaching Hospital, I. P. Pavlova 6, 772 00 Olomouc, Czech Republic. vinsiva@fnol.cz
Král
V
V
Neoral
C
C
Bohanes
T
T
Aujeský
R
R
Kolek
V
V
Grygárková
I
I
Hajdúch
M
M
Tichý
T
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging